Search - tctmd.com

Displaying 81 - 100 of 110

Sort: Relevancy | Date

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

Presentation TCT 2013

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

Presenter: Kenneth Rosenfield

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Daily News

La Reestenosis Intracraneal Intra Stent acarrea un Mayor Riesgo de sufrir Episodios Isquémicos

Yael L. Maxwell

August 30, 2013

News Daily News

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Yael L. Maxwell

August 30, 2013

News Daily News

Los Balones liberadores de Fármacos Reducen la RLD en Diabéticos con Isquemia Crítica de las Extremidades

Jason Kahn

July 05, 2013

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

Paclitaxel Delivery Key to PAD Intervention

Caitlin E. Cox

May 22, 2013

News Daily News

Los SLF de Rescate son Efectivos en Pacientes con ICE y Lesiones por Debajo de la Rodilla

April 19, 2013

News Daily News

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

April 19, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

April 12, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Presenter: Antonio Micari

April 03, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

News Daily News

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

Caitlin E. Cox

December 09, 2012

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

Presentation

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

Presenter: Michael Werk

December 06, 2012

Presentation TCT 2012

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Presenter: Dierk Scheinert

October 23, 2012

Advertisement

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

La Reestenosis Intracraneal Intra Stent acarrea un Mayor Riesgo de sufrir Episodios Isquémicos

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Los Balones liberadores de Fármacos Reducen la RLD en Diabéticos con Isquemia Crítica de las Extremidades

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Paclitaxel Delivery Key to PAD Intervention

Los SLF de Rescate son Efectivos en Pacientes con ICE y Lesiones por Debajo de la Rodilla

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content